Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
BMS' Zeposia comes up short in Crohn's disease study
Interim analysis of Bristol Myers Squibb’s 12-week induction trial of Zeposia in Crohn’s disease has failed to achieve its primary endpoint.
Kevin Dunleavy
Mar 29, 2024 8:15am
Pfizer shifts creative to Publicis in latest marketing move
Mar 28, 2024 10:31am
Big Pharma CEOs offer China renewed interest, policy advice
Mar 26, 2024 11:46am
EU regulator signs off on Novo's weekly insulin and other meds
Mar 22, 2024 11:39am
J&J sues ex-staffer for allegedly taking secret docs to Pfizer
Mar 21, 2024 9:08am
COVID vaccine sales come up short again for BioNTech
Mar 20, 2024 11:33am